Thank you, Tom. We will start with revenues. And again, the third quarter was another solid quarter for us. Sales came in at 260 million SEK. That was down 1% both in SEK and also on an FX-adjusted basis. But it is again worth remembering that Q3 last year was a really strong quarter, partly also because of delayed orders from Q2 2025. So that quarter had a growth of almost 14% and a tough, tough comparison. And for the first nine months, sales are up 4%, or 5% in local currencies, at 750 million SEK. Then, for the first nine months, the average US dollar rate, which is of very high importance to us. That was 9.39 compared to 9.95 last year. So it was down significantly for this quarter. As such, the currency effect on sales was neutral. However, on the cost side, the Israeli shekel, which is very important for us, has continued to be strong against the US dollar. And that affects our margins negatively. Looking at the business areas, the split was 54% for Educational Products and 46% for Industry in this quarter. Educational Products was then up 1% or 2% in local currencies. And for the first nine months, revenue was up 8%. As Tom mentioned, the large positive within this area this quarter and also last quarter is the US sales, which were up 49% compared with Q3 last year and 19% if we compare to Q2. And that quarter was, in turn, stronger than any other quarter in 2025. And the Americas region as a whole grew by 30%. EMEA was down 31%, as Tom mentioned; this is primarily because of several large orders in the comparison quarter, particularly in Poland, but also in, for example, Portugal and Romania.
They were not repeated.
However, for this quarter, we saw strong numbers in the Netherlands and the Czech Republic. And again, sales per country. They do vary a lot between periods depending on when large procurements take place.
But EMEA has been very strong this year. And for the first nine months, it is still up by 28%. And we do have a positive view on demand for this region also going forward. APAC was down a bit again, mainly due to lower sales in China. Japan was stronger this quarter, as Tom mentioned. We did commence operations in our new companies in Hong Kong and in China during the quarter. Our simulation area, Ultrasound, continues to grow by 14%. This whole year has been very positive for this area. We also see a bright outlook with new products such as Aeris, while robotic surgery increased by close to 20%, whereas minimally invasive surgery and medical device, including emergency medicine, decreased. Industry was down 4% or 5% in local currencies, license revenues increased 16% to 76 million, while simulator sales to medical device companies were weaker. And we can see that on this. On the next slide, when we look at our revenue streams, license revenues account for 29% of our total revenues this quarter. They were 25% in Q3 2025, and for the first nine months, license revenues were up 10% to almost 230 million, or 30% of sales, a bit more than 2025 when it was 29%. So license revenues have stayed at a good level throughout the year. And this quarter too. Then they came from several of our robotics customers. We also saw increased activity from robotics manufacturers during the quarter, as Tom talked about, which creates potential for future license revenue. And regarding Intuitive, as we said in the Q2 report, we assessed the total revenue loss for 2026, attributable to the memorandum of understanding to be less than the range of 60 to 90 million. We indicated this earlier. So. So this still stands, even though it is still too early to say how this will develop going forward. Simulator sales as a whole, meaning both Educational Products and Industry, were down 7% to 143 million Swedish kronor. Simulator sales were flat. So the decrease comes from Industry, where sales of simulators to medical device companies were 23 million. As we said before, this business is lumpy. It depends on when customers place their often large orders. Underlying demand is good, and we have a high share of recurring customers. And for the first nine months, simulator sales are up 3%. In total, it was up 9% and then down 22%. Development revenues were 16 million. That is slightly higher than Q2, but weaker than Q3 last year. And regarding the project for the Defense Ministry in the Southeast Asian country, the hardware was delivered during this quarter, and that was almost 10 million in revenue, meaning that development revenues were 1.7 million. And the project is now, as we heard, largely completed; we have approximately 4.5 million remaining. And we expect to recognize that in Q4. Service revenues were really strong for the quarter, up 15%, and September was a really strong month for us. Moving then on to costs and margins. Our gross margin for the quarter was 68%. Three percentage points higher than in the comparison quarter. And here we have both positive and negative effects. Tom mentioned them. Let me go through them again. On the positive side, there is a higher share of license revenues. That is positive for the gross margin. Also, the share of direct sales, which is primarily attributable to the US, was higher. That was higher. And our price increases continue to have an effect. We are also seeing results from the cost management programs we have started in production, which is also positive.
And then on the negative side, the hardware delivery for the defense project that had a lower margin and also currency effects have had a negative impact for the quarter of approximately 1.3 percentage points. For the first nine months, the gross margin was 68%. And here we see a negative currency effect of 1.1 percentage points. Sales costs were 21% of sales, or 55 million. Here in this quarter. We had an item of just below 3 million of a more occasional nature that is related to commissions to distributors. And this varies depending on the country in which the sales take place. We have this set up for a few countries, and also if we compare to Q2, we did not record any refunds of US customs duties this quarter. We did that in Q2, and we will also have refunds in Q4. Admin costs were 8% of sales, as in Q2. The costs include costs for the work on the change of listing to the Nasdaq main market, and it was exactly the same amount as in Q2, 1.1 million. We still expect this to take place next year. We also had a non-recurring positive item of just below 3 million related to IFRS 16 within admin, and the corresponding item is then in the finance net negative of the same amount. So this is a reclassification. R&D costs were 24% of sales, totaling 63 million. We capitalized approximately 10 million. It was a bit higher than last year, but 3.3 million lower if we compare to Q2. Also during this quarter, we started to amortize a few larger projects that we had been capitalizing on and that were now finished. And that also increased our costs on this line by approximately 1.4 million. Other operating income and operating costs include a lot of revaluation items. And this had a smaller negative impact this quarter of 4 million SEK. The revaluations themselves. They were just below 3 million. And then we also have the warrant programs that we have here. And that was just about 1 million for the quarter. So following this, our EBIT or operating profit for the quarter was 32 million, a margin of 12%. If we adjust for FX effects, EBIT for the quarter was 39 million, or 15%. And for the first nine months, we also had a margin of 12% and currency-adjusted. That was 16%. Looking at our organization, we were 324 people at the end of Q3. That is four fewer than at the end of Q3 last year, and five more than at the end of Q2 compared with last year. The decrease is in the US and UK, mainly related to the restructuring of the sales force following the acquisition of Intuitive. While we have added a few people in Israel as well as in Sweden, and since we have also started operations in our new companies in Hong Kong and China, this is also a region where we are growing. We are adding a few people. So adjusted EBIT, then EBIT, excluding amortization on surplus values related to our acquisitions. So we have our financial goal of 15%. The result for the quarter was 38 million SEK. That is an increase of 15%, a margin of 15%, and also in line with our financial target of at least 15%. If we adjust for FX effects the same way as we do for Adjusted EBIT, the margin was 17%. And for the first nine months, the corresponding figures were 14% or FX-adjusted 18%. So, a clear improvement for our adjusted EBIT. And as we have said, profitability is now essentially in line with our target, while growth is not yet at the target level, which is in line with our assessment that we made for this year.
Finance and taxes. Primarily, this includes interest income on bank deposits, reevaluations, and IFRS 16. As I mentioned before, there was this reclassification item of 2.7, which is also in the finance net. Net profit was 34 million SEK. We had a low tax expense this quarter that was due to the final tax return in our Israeli company, which resulted in a positive adjustment for the quarter. And then affecting the effective tax rate is also the fact that we have non-deductible amortization in our P&L. And for the quarter, they were approximately 6 million SEK. Cash flow was good. Operating activities were 43 million compared with a slight negative for Q3 last year. Working capital was slightly negative at minus 7 million SEK. And both inventories and accounts receivable increased a bit for the first nine months. Then cash flow from operating activities is positive 123 million. We also have positive cash flow from working capital for the period. And as you can see from the gray line there, accounts receivable in relation to sales continue to be at a good level. Investing activities for the quarter are mainly in development costs. We did invest in our new production facility in Tel Aviv, but that started and the facilities were commissioned at the end of Q2. That in total is an investment of 21 million, of which 14 million is in 2026. At the end of the quarter, our cash position was 675 million SEK.